Market Research Logo

Global Over-the-Counter Drug Market 2016-2020

Global Over-the-Counter Drug Market 2016-2020

About OTC Drugs

OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. They are sold through hospitals, pharmaceutical stores, grocery stores, catalogs, and online retail stores.

Technavio’s analysts forecast the global over-the-counter (OTC) drug market to grow at a CAGR of 6.19% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global over-the-counter (OTC) drug market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of OTC drugs used to treat disorders, including gastrointestinal disorders, pain, and dermatological and respiratory disorders.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Over-The-Counter (OTC) Drug Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer HealthCare
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson
  • Pfizer
  • Sanofi
Other prominent vendors
  • Abbott
  • Achelios Therapeutics
  • American Health
  • Amgen
  • Arena Pharmaceuticals
  • AstraZeneca
  • BioGaia
  • Bristol Myers Squibb
  • Bukwang Pharmaceutica
  • Chr. Hansen
  • Cipla
  • CoLucid
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • DSM
  • Eisai
  • Eli Lilly
  • EMS
  • Euradite
  • Friggs
  • Genomma Lab Internacional
  • Glanbia
  • Herbalife
  • Himalaya Drug Company
  • Hypermarcas
  • Immune Pharmaceuticals
  • Innovative Med Concepts
  • Mcneil consumer healthcare
  • Mead Johnson
  • Merck
  • Mitsubishi Tanabe Pharma
  • NeurAxon
  • Omega Pharma
  • OptiNose
  • Pain Therapeutics
  • Procter & Gamble
  • Reckitt Benckiser
  • SAVA
  • Sigma Pharmaceuticals
  • Sun Pharma
  • Taisho Pharmaceuticals
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals
  • UCB
  • Unifarma Global Consumer healthcare
  • Valeant Pharmaceuticals
  • Vida Laboratories
Market driver
  • Switching of medications from prescription to OTC
  • For a full, detailed list, view our report
Market challenge
  • Counterfeit drugs
  • For a full, detailed list, view our report
Market trend
  • Accelerated use of online resources
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Over-The-Counter (OTC) Drug Market 2016-2020

Technavio recognizes the following companies as the key players in the global over-the-counter (OTC) drug market: GSK, Johnson & Johnson, Pfizer, Bayer HealthCare, and Sanofi.

Other Prominent Vendors in the market are: Abbott, Achelios Therapeutics, American Health, Amgen, Arena Pharmaceuticals, AstraZeneca, BioGaia, Bristol Myers Squibb, Bukwang Pharmaceutica, Chr. Hansen, Cipla, CoLucid, Daiichi Sankyo, Dr. Reddy's Laboratories, DSM, Eisai, Eli Lilly, EMS, Euradite, Friggs, Genomma Lab Internacional, Glanbia, Herbalife, Himalaya Drug Company, Hypermarcas, Immune Pharmaceuticals, Innovative Med Concepts, Mcneil consumer healthcare, Mead Johnson, Merck, Mitsubishi Tanabe Pharma, NeurAxon, Omega Pharma, OptiNose¸ Pain Therapeutics, Procter & Gamble, Reckitt Benckiser, SAVA, Sigma Pharmaceuticals, Sun Pharma, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals, UCB, Unifarma Global Consumer healthcare, Valeant Pharmaceuticals, and Vida Laboratories.

Commenting on the report, an analyst from Technavio’s team said: “Promotion and marketing initiatives will be a key trend for market growth. Vendors in this market are spending heavily on promotional activities targeted at both the healthy population and those with illnesses. They are trying to build a larger consumer base through marketing campaigns and activities through different media platforms. Marketing strategies for OTC products are very important, especially since these products lose the patent and enter the generic market, resulting in competition.”

According to the report, one of the key drivers for market growth will be rise in self-medication. The growing healthcare costs and an increase in the older population demand the need for better accessibility and affordability of healthcare services. Self-medication with non-prescription drugs play an important role in this and help in improving the accessibility and cost-benefits of healthcare services. Apart from this, the increase in self-care and self-medication is influenced by factors such as lifestyle, socioeconomic factors, and easy accessibility of drugs.

Further, the report states that presence of counterfeit drugs will be a challenge for the market. The sale of counterfeit OTC drugs in the market is increasing, and this problem is usually unreported to the regulatory authorities in majority of the cases. For instance, in April 2014, it was reported that over 2 million counterfeit drugs were seized from France, which included about 1 million packets of fake aspirin, which contained sugar in place of the API. It is estimated that counterfeit drugs account for 10% of the global market, as compared to 1% in the developed world, and the market for these drugs is on a rise. In the US, allergy OTC drugs are among the most counterfeited. Similarly, in 2015, over $100,000 worth fake medicines from the Philippines drugs market were seized.

Companies Mentioned

GSK, Johnson & Johnson, Pfizer, Bayer HealthCare, Sanofi, Abbott, Achelios Therapeutics, American Health, Amgen, Arena Pharmaceuticals, AstraZeneca, BioGaia, Bristol Myers Squibb, Bukwang Pharmaceutica, Chr. Hansen, Cipla, CoLucid, Daiichi Sankyo, Dr. Reddy's Laboratories, DSM, Eisai, Eli Lilly, EMS, Euradite, Friggs, Genomma Lab Internacional, Glanbia, Herbalife, Himalaya Drug Company, Hypermarcas, Immune Pharmaceuticals, Innovative Med Concepts, Mcneil consumer healthcare, Mead Johnson, Merck, Mitsubishi Tanabe Pharma, NeurAxon, Omega Pharma, OptiNose¸ Pain Therapeutics, Procter & Gamble, Reckitt Benckiser, SAVA, Sigma Pharmaceuticals, Sun Pharma, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals, UCB, Unifarma Global Consumer healthcare, Valeant Pharmaceuticals, Vida Laboratories.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Key customer segments of OTC drugs market
  • OTC drugs: An overview
    • Table Comparison between prescription and OTC drugs
    • Table Advantages and disadvantages of OTC drugs
    • Regulatory pathways for OTC approval
      • Table Key regulatory bodies for OTC approval
    • FDA OTC drug approval process
      • Table FDA OTC drug approval process
      • Table Mechanisms to amend OTC drug monograph
      • Table Comparison of OTC NDA and OTC monograph process
    • Strategies to penetrate OTC pharmaceuticals in emerging markets
      • Table Strategies to establish OTC pharmaceuticals in emerging markets
      • Table Strategies to establish OTC pharmaceuticals in established markets
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global OTC drugs market 2015-2020 ($ billions)
      • Table Few prescription to OTC switches before the expiry of patents
      • Table Growth potential of various therapy areas in OTC market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by therapeutic class
    • Table Segmentation of global OTC pharmaceuticals by therapeutic class
    • Table Segmentation of global OTC pharmaceuticals market by therapeutic class 2015
    • Table Global OTC market segmentation: Growth cycle analysis
  • Global respiratory OTC drugs market
    • Market overview
      • Table List of drugs that underwent Rx-to-OTC switch
      • Table OTC medications for upper respiratory infections
      • Table Global respiratory OTC drugs market 2015-2020 ($ billions)
  • Global dietary supplements market
    • Table Recommendation of dietary supplements by health professionals
    • Market overview
      • Table Global dietary supplements market 2015-2020 ($ billions)
  • Global gastrointestinal OTC drugs market
    • Market overview
      • Table Drugs underwent Rx-to-OTC switch in US
      • Table Global gastrointestinal OTC drugs market 2015-2020 ($ billions)
    • Market segmentation by therapeutic class of drug
  • Global OTC pain medications market
    • Market overview
      • Table Global OTC pain medications market 2015-2020 ($ billions)
    • Market segmentation by therapeutic class of drug
      • Table Global OTC analgesics market by therapeutic class of drug 2015
  • Market segmentation by route of administration
    • Table Segmentation of global OTC drugs market by route of administration 2015
    • Oral
    • Topical
    • Parenteral
  • Geographical segmentation
    • Global OTC drugs market by geography 2015-2020
      • Table Global OTC drugs market by geography 2015-2020
      • Table Percentage share of global OTC drugs market by geography 2015 and 2020
      • Table Global OTC drugs market segmentation by geography 2015-2020 ($ billions)
      • Table Global share of OTC drugs market by geography 2015
      • Table Global OTC drugs market: Country analysis based on revenue and growth rate
    • OTC drugs market in Americas
      • Table OTC drugs market in Americas 2015-2020 ($ billions)
    • OTC drugs market in US
      • Table Major attributes of OTC medicines
      • Table OTC drugs market in US 2015-2020 ($ billions)
    • OTC drugs market in EMEA
      • Table OTC drugs market in EMEA 2015-2020 ($ billions)
      • Table OTC market in EMEA: Short term versus long term 2015-2017
      • Table Distribution channels of key countries in Europe
      • Table Percentage share of Europe and MEA in OTC drugs market in EMEA 2015
    • OTC drugs market in Germany
      • Table Snapshot of OTC market in Germany
      • Table Distribution system of OTC drugs market in Germany
      • Table YoY OTC drug revenues from distribution chains in Germany 2014-2015 ($ millions)
      • Table OTC drugs market in Germany 2015-2020 ($ billions)
    • OTC drugs market in France
      • Table Key takeaways from market dynamics of European countries 2015-2017
      • Table OTC drugs market in France 2015-2020 ($ billions)
    • OTC drugs market in APAC
      • Table OTC drugs market in APAC 2015-2020 ($ billions)
    • OTC drugs market in China
      • Table OTC drugs market in China 2015-2020 ($ billions)
    • OTC drugs market in Japan
      • Table OTC drugs market in Japan 2015-2020 ($ billions)
    • OTC drugs market in India
      • Table Growth factors of OTC market in India
      • Table OTC drugs market in India 2015-2020 ($ billions)
  • Market drivers
    • Switching of medications from prescription to OTC
      • Table Factors promoting and inhibiting switch of Rx to OTC
      • Table Rx to OTC switch in US 2011-2015
      • Table Potential future candidates for OTC medications
    • Lenient regulatory framework and distribution channel
    • Cost-effective OTC drugs
      • Table Saving made by swapping branded for non-prescription generics for few drugs
    • Rise in self-medication
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Counterfeit drugs
    • Lack of valid literature
    • High expenditure on advertisements
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Accelerated use of online resources
    • Promotions and marketing initiatives
      • Table Promotional activities during various stages of OTC product lifecycle
    • Strategic alliances
  • Vendor landscape
    • Competitive scenario
      • Table Presence of vendors in different therapy areas in OTC drugs market
      • Table Geographical presence of key vendors in OTC drugs market 2015
      • Table Competitive scenario of global OTC drugs market vendors 2015-2020
      • Table Market share of key vendors based on revenue 2015
  • Key vendor analysis
    • GSK
      • Table GSK: Product category (consumer healthcare) by revenue 2013-2015
      • Table GSK: YoY revenue and growth rate of wellness products 2013-2015 ($ billions)
      • Table GSK: YoY revenue and growth rate of skin health products 2013-2015 ($ millions)
      • Table GSK: Geographical segmentation by revenue (consumer health) 2015
      • Table GSK: Metrics analysis
    • Johnson & Johnson
      • Table Johnson & Johnson: Product category (consumer healthcare) by revenue 2014
      • Table Johnson & Johnson: Revenue and growth rate of OTC products 2013-2015 ($ billions)
      • Table Johnson & Johnson: Geographical segmentation by revenue (consumer healthcare) 2015
      • Table Johnson & Johnson: Metrics analysis
    • Pfizer
      • Table Pfizer: YoY revenue and growth rate of OTC drugs 2013-2015 ($ billions)
      • Table Pfizer: Metrics analysis
    • Bayer HealthCare
      • Table Bayer HealthCare: Consumer health segmentation by revenue 2015
      • Table Bayer HealthCare: Geographic segmentation of consumer healthcare segment 2015
      • Table Bayer HealthCare: YoY revenue and growth rate of Aspirin 2013-2015 ($ millions)
      • Table Bayer HealthCare: YoY revenue and growth rate of Aleve 2013-2015 ($ millions)
      • Table Bayer HealthCare: YoY revenue and growth rate of Bepanthen/Bepanthol 2013-2015 ($ millions)
      • Table Bayer HealthCare: YoY revenue and growth rate of Canesten 2013-2015 ($ millions)
      • Table Bayer HealthCare: Metrics analysis
    • Sanofi
      • Table Sanofi: Geographical segmentation by revenue 2015 (consumer healthcare)
      • Table Sanofi: YoY revenue and growth rate of Allegra 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Doliprane 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Essentiale 2012-2014 ($ million)
      • Table Sanofi: YoY revenue and growth rate of Enterogermina 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue comparison of Nasacort 2014-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Buscopan 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Dulcolax 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Mucosolvan 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Pharmaton 2013-2015 ($ millions)
      • Table Sanofi: Metrics analysis
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report